Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Munich - Delayed Quote EUR

TME Pharma NV (0N6A.MU)

Compare
0.0710
0.0000
(0.00%)
At close: February 28 at 8:08:40 AM GMT+1
Currency in EUR All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
5,610
5,624
11,996
13,451
5,781
Operating Income
-5,610
-5,624
-11,996
-13,451
-5,781
Net Non Operating Interest Income Expense
-740
-1,119
-3,097
-1,185
-4,637
Pretax Income
-6,323
-6,734
-15,126
-14,452
-10,406
Tax Provision
--
2
7
1
--
Net Income Common Stockholders
-6,325
-6,736
-15,132
-14,452
-10,405
Diluted NI Available to Com Stockholders
-6,325
-6,736
-15,132
-14,452
-10,405
Basic EPS
-0.35
-1.00
-9.59
-14.80
-21.63
Diluted EPS
-0.35
-1.00
-9.59
-14.80
-21.63
Basic Average Shares
22,577.4590
6,729.8620
1,577.4880
976.1540
478.6990
Diluted Average Shares
22,577.4590
6,729.8620
1,577.4880
976.1540
478.6990
Total Operating Income as Reported
-5,583
-5,615
-12,029
-13,267
-5,769
Total Expenses
5,610
5,624
11,996
13,451
5,781
Net Income from Continuing & Discontinued Operation
-6,325
-6,736
-15,132
-14,452
-10,405
Normalized Income
-6,325
-6,736
-15,132
-14,452
-10,405
Interest Income
158
399
303
319
418
Interest Expense
898
1,518
3,400
1,504
5,055
Net Interest Income
-740
-1,119
-3,097
-1,185
-4,637
EBIT
-5,425
-5,216
-11,726
-12,948
-5,351
EBITDA
-5,293
-5,072
-11,634
-12,882
-5,288
Reconciled Depreciation
132
144
92
66
63
Net Income from Continuing Operation Net Minority Interest
-6,325
-6,736
-15,132
-14,452
-10,405
Normalized EBITDA
-5,293
-5,072
-11,634
-12,882
-5,288
Tax Rate for Calcs
--
0.0002
0.0002
0.0003
--
12/31/2020 - 2/6/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.